Remote Assisted Home Dressing vs. Outpatient Medication of Central Venous Catheter (Peripherally Inserted Central Venous Catheter): Clinical Trial A.R.C.O. (Remote Assistance Oncology Caregiver).

PICC cancer patient nursing education quality of life telenursing

Journal

Nursing reports (Pavia, Italy)
ISSN: 2039-4403
Titre abrégé: Nurs Rep
Pays: Switzerland
ID NLM: 101592662

Informations de publication

Date de publication:
11 Jun 2024
Historique:
received: 06 03 2024
revised: 03 06 2024
accepted: 03 06 2024
medline: 26 6 2024
pubmed: 26 6 2024
entrez: 26 6 2024
Statut: epublish

Résumé

Management of PICC dressing can be performed at home by the patient through adequate training and telenursing. This trial verifies that the incidence of catheter-related complications in home patients, assisted by telenursing, is not greater than that observed in outpatients. This clinical trial is composed of 72 patients with malignant tumors who underwent long-term chemotherapy with PICC insertion. They were randomly divided into an experimental group (33 cases) and a calibration group (39 cases). The control group received outpatient dressing for the PICC at the hospital, while the experimental group received a telenursing intervention about the management of the PICC. The incidence of catheter-related infections, the ability of self-management, and a rough cost/benefit estimation were compared between the two groups. This trial was performed according to the CONSORT 2010 checklist. The two groups do not significantly differ in relation to age, sex, and PICCs in terms of the body side insertion, the type of dressing, and the agents used for cleaning. The analysis of the results showed that in the home-managed group, the clinical events reported during the connection were higher when compared with the outpatient group ( The use of telenursing for patient education in cancer centers can reduce nurses' working time, improving the self-management capacity of patients with a long-term PICC. This trial was retrospectively registered with the Clinical Trial Gov on the 18 May 2023 with registration number NCT05880420.

Sections du résumé

BACKGROUND BACKGROUND
Management of PICC dressing can be performed at home by the patient through adequate training and telenursing. This trial verifies that the incidence of catheter-related complications in home patients, assisted by telenursing, is not greater than that observed in outpatients.
METHODS METHODS
This clinical trial is composed of 72 patients with malignant tumors who underwent long-term chemotherapy with PICC insertion. They were randomly divided into an experimental group (33 cases) and a calibration group (39 cases). The control group received outpatient dressing for the PICC at the hospital, while the experimental group received a telenursing intervention about the management of the PICC. The incidence of catheter-related infections, the ability of self-management, and a rough cost/benefit estimation were compared between the two groups. This trial was performed according to the CONSORT 2010 checklist.
RESULTS RESULTS
The two groups do not significantly differ in relation to age, sex, and PICCs in terms of the body side insertion, the type of dressing, and the agents used for cleaning. The analysis of the results showed that in the home-managed group, the clinical events reported during the connection were higher when compared with the outpatient group (
CONCLUSION CONCLUSIONS
The use of telenursing for patient education in cancer centers can reduce nurses' working time, improving the self-management capacity of patients with a long-term PICC. This trial was retrospectively registered with the Clinical Trial Gov on the 18 May 2023 with registration number NCT05880420.

Identifiants

pubmed: 38921720
pii: nursrep14020110
doi: 10.3390/nursrep14020110
doi:

Banques de données

ClinicalTrials.gov
['NCT05880420']

Types de publication

Journal Article

Langues

eng

Pagination

1468-1476

Subventions

Organisme : ATS - Doxea S.r.l., Beps Engineering S.r.l., Haedapp S.r.l.
ID : bando Prims-E

Auteurs

Paolo Basili (P)

Technical, Rehabilitation, Assistance and Research Direction, Vascular Access Specialist IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Ilaria Farina (I)

Department of Radiation Oncology, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Irene Terrenato (I)

Clinical Trial Center-Biostatistics & Bioinformatics, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Jacopo Centini (J)

Nursing, Technical, Rehabilitation, Assistance and Research Direction IFO, IRCCS Regina Elena, National Cancer Institute, 00144 Rome, Italy.

Nina Volpe (N)

Nursing, Technical, Rehabilitation, Assistance and Research Direction IFO, IRCCS Regina Elena, National Cancer Institute, 00144 Rome, Italy.

Vanessa Rizzo (V)

Technical, Rehabilitation, Assistance and Research Direction, Vascular Access Specialist IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Laura Agoglia (L)

Nuova Sair, 00131 Rome, Italy.

Albina Paterniani (A)

School of Nursing, IRCCS Regina Elena National Cancer, 00144 Rome, Italy.

Pasquale Aprea (P)

Vascular Access Unit, IRCCS-Fondazione G. Pascale National Cancer Institute, 80131 Napoli, Italy.

Prisco Calignano (P)

Department of Hematology, IRCCS-Fondazione G. Pascale National Cancer Institute, 80131 Napoli, Italy.

Fabrizio Petrone (F)

Nursing, Technical, Rehabilitation, Assistance and Research Direction IFO, IRCCS Regina Elena, National Cancer Institute, 00144 Rome, Italy.

Gennaro Ciliberto (G)

Scientific Directorate, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Classifications MeSH